中国基层医药
中國基層醫藥
중국기층의약
Chinese Journal of Primary Medicine and Pharmacy
2015年
21期
3241-3244
,共4页
邓亮%李淑芳%林伟章%劳武健
鄧亮%李淑芳%林偉章%勞武健
산량%리숙방%림위장%로무건
螺杆菌,幽门%多西环素%左氧氟沙星%枸橼酸铋钾%奥美拉唑
螺桿菌,幽門%多西環素%左氧氟沙星%枸櫞痠鉍鉀%奧美拉唑
라간균,유문%다서배소%좌양불사성%구연산필갑%오미랍서
Helicobacter,pylori%Doxycycline%Levofloxacin%Bismuth potassium citrate%Omeprazole
目的:观察多西环素、左氧氟沙星、枸橼酸铋钾联合奥美拉唑根除幽门螺杆菌的效果及安全性。方法选择幽门螺杆菌阳性患者240例,按照数字表法随机分为治疗组(多西环素+左氧氟沙星+枸橼酸铋钾+奥美拉唑)60例、对照组 A(多西环素+左氧氟沙星+奥美拉唑)60例、对照组 B(阿莫西林+克拉霉素+枸橼酸铋钾+奥美拉唑)60例、对照组 C(阿莫西林+克拉霉素+奥美拉唑)60例。根除幽门螺杆菌治疗疗程为7 d。胃炎患者疗程结束后停药,消化性溃疡患者7 d 后再服奥美拉唑5周后停药,停药2周后复查14 C 呼气试验,观察临床效果及不良反应。结果治疗组、对照组 A、对照组 B、对照组 C 幽门螺杆菌根除率分别为93.3%、80.0%、91.7%、75.0%,治疗组与对照组 A 比较根除率明显升高(χ2=4.61,P <0.05),治疗组与对照组 C 比较根除率明显升高(χ2=7.57,P <0.05),治疗组与对照组 B 比较根除率差异无统计学意义(χ2=0.12,P >0.05)。对照组 B 口腔异味发生率较治疗组高(χ2=6.56,P <0.05)。对照组 C 口腔异味发生率较治疗组高(χ2=5.46,P <0.05)。结论多西环素、左氧氟沙星、枸橼酸铋钾联合奥美拉唑可显著提高幽门螺杆菌根除率,且价格低廉,副作用少,无需青霉素皮试,对经济困难或青霉素过敏患者可选择使用。
目的:觀察多西環素、左氧氟沙星、枸櫞痠鉍鉀聯閤奧美拉唑根除幽門螺桿菌的效果及安全性。方法選擇幽門螺桿菌暘性患者240例,按照數字錶法隨機分為治療組(多西環素+左氧氟沙星+枸櫞痠鉍鉀+奧美拉唑)60例、對照組 A(多西環素+左氧氟沙星+奧美拉唑)60例、對照組 B(阿莫西林+剋拉黴素+枸櫞痠鉍鉀+奧美拉唑)60例、對照組 C(阿莫西林+剋拉黴素+奧美拉唑)60例。根除幽門螺桿菌治療療程為7 d。胃炎患者療程結束後停藥,消化性潰瘍患者7 d 後再服奧美拉唑5週後停藥,停藥2週後複查14 C 呼氣試驗,觀察臨床效果及不良反應。結果治療組、對照組 A、對照組 B、對照組 C 幽門螺桿菌根除率分彆為93.3%、80.0%、91.7%、75.0%,治療組與對照組 A 比較根除率明顯升高(χ2=4.61,P <0.05),治療組與對照組 C 比較根除率明顯升高(χ2=7.57,P <0.05),治療組與對照組 B 比較根除率差異無統計學意義(χ2=0.12,P >0.05)。對照組 B 口腔異味髮生率較治療組高(χ2=6.56,P <0.05)。對照組 C 口腔異味髮生率較治療組高(χ2=5.46,P <0.05)。結論多西環素、左氧氟沙星、枸櫞痠鉍鉀聯閤奧美拉唑可顯著提高幽門螺桿菌根除率,且價格低廉,副作用少,無需青黴素皮試,對經濟睏難或青黴素過敏患者可選擇使用。
목적:관찰다서배소、좌양불사성、구연산필갑연합오미랍서근제유문라간균적효과급안전성。방법선택유문라간균양성환자240례,안조수자표법수궤분위치료조(다서배소+좌양불사성+구연산필갑+오미랍서)60례、대조조 A(다서배소+좌양불사성+오미랍서)60례、대조조 B(아막서림+극랍매소+구연산필갑+오미랍서)60례、대조조 C(아막서림+극랍매소+오미랍서)60례。근제유문라간균치료료정위7 d。위염환자료정결속후정약,소화성궤양환자7 d 후재복오미랍서5주후정약,정약2주후복사14 C 호기시험,관찰림상효과급불량반응。결과치료조、대조조 A、대조조 B、대조조 C 유문라간균근제솔분별위93.3%、80.0%、91.7%、75.0%,치료조여대조조 A 비교근제솔명현승고(χ2=4.61,P <0.05),치료조여대조조 C 비교근제솔명현승고(χ2=7.57,P <0.05),치료조여대조조 B 비교근제솔차이무통계학의의(χ2=0.12,P >0.05)。대조조 B 구강이미발생솔교치료조고(χ2=6.56,P <0.05)。대조조 C 구강이미발생솔교치료조고(χ2=5.46,P <0.05)。결론다서배소、좌양불사성、구연산필갑연합오미랍서가현저제고유문라간균근제솔,차개격저렴,부작용소,무수청매소피시,대경제곤난혹청매소과민환자가선택사용。
Objective To observe the effect and safety of helicobacter pylori eradication by doxycycline, levofloxacin,bismuth potassium citrate combined with omeprazole.Methods 240 patients who infected helicobacter pylori were selected,and were randomly divided into four groups:treatment group(doxycycline,levofloxacin,bismuth potassium citrate,omeprazole),control group A(doxycycline,levofloxacin,omeprazole),control group B(amoxicillin, clarithromycin,bismuth potassium citrate,omeprazole),control group C (amoxicillin,clarithromycin,omeprazole), 60 patients in each group.Helicobacter pylori eradication treatment for 7 days,patients with gastritis stop after the course of the treatment,peptic ulcer patients continue taking omeprazole 5 weeks after 7 days treatment.All patients stopped medicine 2 weeks accepted 14 carbon breath test.And adverse events were investigated.Results In the treatment group and the control group A,B,C,the helicobacter pylori eradication rates were 93.3%,80.0%,91.7%, 75.0%.Compared with group A,the treatment group helicobacter pylori eradication rate increased significantly(χ2 =4.61,P <0.05 ).Compared with group C,the treatment group helicobacter pylori eradication rate increased significantly(χ2 =7.57,P <0.05).But compared with group B,the treatment group helicobacter pylori eradication rate had no significant difference(χ2 =0.12,P >0.05).Compared with the treatment group,group B had high inci-dence of oral odor(χ2 =6.56,P <0.05).Compared with the treatment group,group C had high incidence of oral odor (χ2 =5.46,P <0.05).Conclusion Doxycycline,levofloxacin,bismuth potassium citrate combined with omeprazole can improve the helicobacter pylori eradication rate significantly,and with low price,has little side effect,no need of penicillin skin test,can used for the patients poverty or allergic to penicillin.